ESTRO 2024 - Abstract Book

S5125

Physics - Radiomics, functional and biological imaging and outcome prediction

ESTRO 2024

Conclusion:

Oxygen-enhanced changes were measured in the whole prostate on the MR-Linac, demonstrating the feasibility of OE-MRI. Significant signal changes were seen in seven out of the nine patient visits indicating that it is possible to observe a signal change in the prostate induced by the patient breathing 100% oxygen. Oxygen signal changes varied across the cohort which could be due to underlying pathophysiology. Further work is required to assess the accuracy of image registration This technical work on OE-MRI in the whole prostate will be combined with other multiparametric MR imaging techniques to assess feasibility of imaging tumour hypoxia on the MR Linac in a larger study.

Keywords: Oxygen-Enhanced MRI, Hypoxia, Prostate

References:

1. Dubec MJ, Buckley DL, Berks M, Clough A, Gaffney J, Datta A, et al. First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer. Radiotherapy and Oncology. 2023 Jun 1;183. 2. Raaymakers BW, Jürgenliemk-Schulz IM, Bol GH, Glitzner M, Kotte ANTJ, Van Asselen B, et al. First patients treated with a 1.5 T MRI-Linac: Clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment. Phys Med Biol. 2017 Nov 14;62(23):L41–50.

3. O’Connor JPB, Aboagye EO, Adams JE, Aerts HJWL, Barrington SF, Beer AJ, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017 Feb 20;14(3):169–86.

4. Dewhirst MW, Birer SR. Oxygen-enhanced MRI is a major advance in tumor hypoxia imaging. Vol. 76, Cancer Research. American Association for Cancer Research Inc.; 2016. p. 769–72.

5. Bodensteiner D. RayStation: External beam treatment planning system. Medical Dosimetry [Internet]. 2018 Jun 1;43(2):168–76. Available from: https://doi.org/10.1016/j.meddos.2018.02.013